Rohto Pharmaceutical Co (RPHCF) Price & Analysis

Compare

3 Followers

RPHCF Stock Chart & Stats

Day’s Range― - ―

52-Week Range$11.56 - $28.23

Previous CloseN/A

Volume5.49K

Average Volume (3M)0.00

Market Cap

$3.38B

Enterprise Value$501.93B

Total Cash (Recent Filing)$61.71B

Total Debt (Recent Filing)$38.81B

Price to Earnings (P/E)14.5

Beta0.11

Next Earnings

Aug 12, 2025

EPS EstimateN/A

Next Dividend Ex-Date

Sep 29, 2025

Dividend Yield1.28%

Share Statistics

EPS (TTM)0.19

Shares Outstanding236,178,310

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap148.52

Enterprise Value/Revenue1.70

Enterprise Value/Gross Profit2.97

Enterprise Value/Ebitda11.02

Forecast

1Y Price Target

$17.57

Price Target Upside19.36% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering6

Rohto Pharmaceutical Co News

Rohto Pharmaceutical Revises Earnings Forecast Upward

Rohto Pharmaceutical Co ( ($JP:4527) ) has issued an announcement. Rohto Pharmaceutical Co., Ltd. has revised its earnings...

2d ago

Rohto Pharmaceutical Reports Strong Q1 Financial Performance with Revised Forecast

The latest announcement is out from Rohto Pharmaceutical Co ( ($JP:4527) ). Rohto Pharmaceutical Co. reported a significant...

2d ago

Rohto Pharmaceutical Announces Dividend Increase

Rohto Pharmaceutical Co ( ($JP:4527) ) just unveiled an announcement. Rohto Pharmaceutical Co., Ltd. announced a resolution to...

3M ago

Rohto Pharmaceutical Reports Strong Sales Growth

Rohto Pharmaceutical Co ( ($RPHCF) ) has released its Q4 earnings. Here is a breakdown of the information...

3M ago

Rohto Pharmaceutical Unveils 2025-2035 Growth Strategy

Rohto Pharmaceutical Co ( ($JP:4527) ) has issued an update. Rohto Pharmaceutical Co., Ltd. has announced its Medium-...

3M ago

Rohto Pharmaceutical Reports FY2025 Financial Results with Increased Sales and Dividends

An update from Rohto Pharmaceutical Co ( ($JP:4527) ) is now available. Rohto Pharmaceutical Co. reported its consolidated...

3M ago

RPHCF Earnings this Week: How Will it Perform?

Rohto Pharmaceutical Co (RPHCF) is scheduled to report 4th quarter earnings on 05/13/2025. Regarding Q4 estimates, Wall Street...

3M ago

Rohto Pharmaceutical Announces Leadership Changes to Drive Future Growth

Rohto Pharmaceutical Co ( ($JP:4527) ) has provided an announcement. Rohto Pharmaceutical Co., Ltd. announced significant leadership changes,...

3M ago

Rohto Pharmaceutical Completes Strategic Share Repurchase

The latest update is out from Rohto Pharmaceutical Co ( ($JP:4527) ). Rohto Pharmaceutical Co., Ltd. announced the...

5M ago

Rohto Pharmaceutical Announces Terms for 2032 Convertible Bonds

Rohto Pharmaceutical Co ( ($JP:4527) ) just unveiled an announcement. Rohto Pharmaceutical Co., Ltd. has announced the terms...

5M ago

Rohto Pharmaceutical downgraded to Underperform from Buy at Jefferies

Jefferies analyst Hisae Kawamoto downgraded Rohto Pharmaceutical (RPHCF) to Underperform from Buy with a price target of 2,450...

9M ago

Rohto Pharmaceutical initiated with a Buy at Jefferies

Jefferies initiated coverage of Rohto Pharmaceutical with a Buy rating and 3,900 yen price target. The analyst initiated...

1y ago

RPHCF FAQ

What was Rohto Pharmaceutical Co ’s price range in the past 12 months?

Rohto Pharmaceutical Co lowest stock price was $11.56 and its highest was $28.23 in the past 12 months.

What is Rohto Pharmaceutical Co ’s market cap?

Rohto Pharmaceutical Co ’s market cap is $3.38B.

When is Rohto Pharmaceutical Co ’s upcoming earnings report date?

Rohto Pharmaceutical Co ’s upcoming earnings report date is Aug 12, 2025 which is in 4 days.

How were Rohto Pharmaceutical Co ’s earnings last quarter?

Rohto Pharmaceutical Co released its earnings results on May 13, 2025. The company reported $0.186 earnings per share for the quarter, beating the consensus estimate of $0.169 by $0.016.

Is Rohto Pharmaceutical Co overvalued?

According to Wall Street analysts Rohto Pharmaceutical Co ’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Rohto Pharmaceutical Co pay dividends?

Rohto Pharmaceutical Co pays a Semiannually dividend of $0.142 which represents an annual dividend yield of 1.28%. See more information on Rohto Pharmaceutical Co dividends here

What is Rohto Pharmaceutical Co ’s EPS estimate?

Rohto Pharmaceutical Co ’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Rohto Pharmaceutical Co have?

Rohto Pharmaceutical Co has 236,178,310 shares outstanding.

What happened to Rohto Pharmaceutical Co ’s price movement after its last earnings report?

Rohto Pharmaceutical Co reported an EPS of $0.186 in its last earnings report, beating expectations of $0.169. Following the earnings report the stock price went up 0.796%.

Which hedge fund is a major shareholder of Rohto Pharmaceutical Co ?

Currently, no hedge funds are holding shares in RPHCF

Company Description

Rohto Pharmaceutical Co

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

Rohto Pharmaceutical Co (RPHCF) Earnings & Revenues

Historic Earnings Reports

RPHCF Stock 12 Month Forecast

Average Price Target

$17.57

▲(19.36% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","27":"$27","14.25":"$14.25","18.5":"$18.5","22.75":"$22.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":23.73,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$23.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.57,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$17.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.86,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$11.86</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,14.25,18.5,22.75,27],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2023","6":"Nov<br/>2024","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.72,15.413076923076924,16.10615384615385,16.79923076923077,17.492307692307694,18.185384615384617,18.87846153846154,19.571538461538463,20.264615384615386,20.95769230769231,21.65076923076923,22.343846153846155,23.036923076923078,{"y":23.73,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.72,14.93923076923077,15.15846153846154,15.377692307692309,15.596923076923078,15.816153846153847,16.035384615384615,16.254615384615384,16.473846153846154,16.693076923076923,16.912307692307692,17.13153846153846,17.35076923076923,{"y":17.57,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.72,14.5,14.280000000000001,14.06,13.84,13.620000000000001,13.4,13.18,12.96,12.74,12.52,12.3,12.08,{"y":11.86,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.47,"date":1630454400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.89,"date":1633046400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.89,"date":1633046400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.36,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.61,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.02,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.68,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.24,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.04,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.42,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.63,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.13,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.72,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >